Rep. Richard McCormick Buys Procter & Gamble Company (The) (NYSE:PG) Stock

Representative Richard McCormick (R-Georgia) recently bought shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on December 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in Procter & Gamble stock on November 5th.

Representative Richard McCormick also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Berkshire Hathaway (NYSE:BRK.B) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Medtronic (NYSE:MDT) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Realty Income (NYSE:O) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Intercontinental Exchange (NYSE:ICE) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 11/5/2025.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 11/5/2025.

Procter & Gamble Stock Up 0.1%

PG opened at $139.82 on Thursday. Procter & Gamble Company has a twelve month low of $138.14 and a twelve month high of $179.99. The company has a 50-day moving average price of $148.25 and a 200 day moving average price of $154.60. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The company has a market cap of $326.72 billion, a PE ratio of 20.41, a price-to-earnings-growth ratio of 4.21 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The business had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter last year, the business posted $1.93 earnings per share. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Sell-side analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is currently 61.75%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wells Fargo & Company reduced their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Raymond James Financial dropped their price objective on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a report on Monday, October 20th. Barclays reduced their price objective on shares of Procter & Gamble from $153.00 to $151.00 and set an “equal weight” rating on the stock in a report on Monday. Berenberg Bank increased their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Finally, BNP Paribas reaffirmed an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $171.40.

Institutional Trading of Procter & Gamble

Institutional investors and hedge funds have recently made changes to their positions in the company. Lantz Financial LLC lifted its stake in Procter & Gamble by 1.2% in the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock valued at $834,000 after buying an additional 64 shares in the last quarter. Orca Investment Management LLC lifted its position in Procter & Gamble by 2.0% in the 2nd quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock valued at $516,000 after acquiring an additional 64 shares in the last quarter. Kondo Wealth Advisors Inc. boosted its stake in Procter & Gamble by 5.2% in the 1st quarter. Kondo Wealth Advisors Inc. now owns 1,324 shares of the company’s stock worth $226,000 after purchasing an additional 65 shares during the period. Silver Oak Securities Incorporated increased its holdings in Procter & Gamble by 0.3% during the 2nd quarter. Silver Oak Securities Incorporated now owns 22,118 shares of the company’s stock worth $3,524,000 after purchasing an additional 65 shares in the last quarter. Finally, Access Financial Services Inc. boosted its position in shares of Procter & Gamble by 0.6% during the second quarter. Access Financial Services Inc. now owns 10,889 shares of the company’s stock worth $1,735,000 after buying an additional 65 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Procter & Gamble news, CEO Gary A. Coombe sold 3,535 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $538,133.05. Following the completion of the transaction, the chief executive officer owned 34,816 shares of the company’s stock, valued at $5,300,039.68. This represents a 9.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares of the company’s stock, valued at $7,139,434.77. The trade was a 7.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 30,308 shares of company stock worth $4,611,852 in the last 90 days. Company insiders own 0.20% of the company’s stock.

About Representative McCormick

Rich McCormick (Republican Party) is a member of the U.S. House, representing Georgia’s 7th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

McCormick (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 7th Congressional District. He declared candidacy for the 2026 election.

Rich McCormick lives in Suwanee, Georgia. McCormick served in the U.S. Marine Corps and the U.S. Navy. He earned an M.B.A. from National University and an M.D. from Morehouse School of Medicine. McCormick’s career experience includes working as an emergency medicine physician with Gwinnett Medical Center and Northside Hospital, a Marine officer instructor with Georgia Tech and Morehouse College, and a pilot.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.